Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Anton Simeonov and Catherine Chen.
Connection Strength

0.580
  1. Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Front Pharmacol. 2020; 11:592737.
    View in: PubMed
    Score: 0.231
  2. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS Pharmacol Transl Sci. 2021 Jun 11; 4(3):1124-1135.
    View in: PubMed
    Score: 0.059
  3. Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics. Sci Rep. 2021 03 24; 11(1):6725.
    View in: PubMed
    Score: 0.059
  4. Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection. Bioorg Med Chem Lett. 2021 05 15; 40:127906.
    View in: PubMed
    Score: 0.058
  5. Biological activity-based modeling identifies antiviral leads against SARS-CoV-2. Nat Biotechnol. 2021 06; 39(6):747-753.
    View in: PubMed
    Score: 0.058
  6. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules. ACS Infect Dis. 2021 06 11; 7(6):1389-1408.
    View in: PubMed
    Score: 0.057
  7. Synergistic and Antagonistic Drug Combinations against SARS-CoV-2. Mol Ther. 2021 02 03; 29(2):873-885.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.